Evidence map›Paper›PMID 37268690›Full record

ArticleNature communications2023

Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZD

Jie Ding, Sung-Jin Lee, Lukas Vlahos, Kanako Yuki, Cara C Rada, Vincent van Unen, Meghah Vuppalapaty, Hui Chen, Asmiti Sura, Aaron K McCormick and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Modulation of miR-23b Wnt/β-catenin Axis Strengthens Endothelial Barrier Properties.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Nitrogen-Boosted HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  13. Article
  14. Development of the blood-brain barrier.Development (Cambridge, England) · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Jie DingDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Sung-Jin LeeSurrozen, Inc. South San Francisco, South San Francisco, CA, 94080, USA.
Lukas VlahosDepartment of Systems Biology, Columbia University, Columbia, NY, 10032, USA.
Kanako YukiDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Cara C RadaDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Vincent van UnenDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID 0000-0001-9339-8430
Meghah VuppalapatySurrozen, Inc. South San Francisco, South San Francisco, CA, 94080, USA.
Hui ChenSurrozen, Inc. South San Francisco, South San Francisco, CA, 94080, USA.
Asmiti SuraSurrozen, Inc. South San Francisco, South San Francisco, CA, 94080, USA.
Aaron K McCormickDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Madeline TomaskeDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Samira AlwahabiDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Huy NguyenSurrozen, Inc. South San Francisco, South San Francisco, CA, 94080, USA.
William NowatzkeSurrozen, Inc. South San Francisco, South San Francisco, CA, 94080, USA.
Lily KimDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Lisa KellyDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Douglas VollrathDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Andrea CalifanoDepartment of Systems Biology, Columbia University, Columbia, NY, 10032, USA.
Wen-Chen YehSurrozen, Inc. South San Francisco, South San Francisco, CA, 94080, USA.ORCID 0000-0002-8837-8301
Yang LiSurrozen, Inc. South San Francisco, South San Francisco, CA, 94080, USA.ORCID 0000-0002-7134-5685
Calvin J KuoDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, 94305, USA. cjkuo@stanford.edu.ORCID 0000-0002-7427-5985
Stanford University · USColumbia University · USStanford Medicine · US

Funding

Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell LevelR35CA197745 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ANDREA CALIFANO · 2015 to 2026
$11.5M
Regulation of actively proliferating and quiescent intestinal stem cellsU01DK085527 · NIDDK · STANFORD UNIVERSITY · PI KUO, CALVIN J · 2009 to 2023
$6.9M
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and TherapyR01DK115728 · NIDDK · STANFORD UNIVERSITY · PI GARCIA, KENAN CHRISTOPHER, KUO, CALVIN J · 2018 to 2022
$3.9M
Regulation of Blood-Brain Barrier Function by the RECK/GPR124/Wnt7 PathwayR01NS100904 · NINDS · STANFORD UNIVERSITY · PI CALVIN J KUO · 2017 to 2026
$3.6M
Program in Translational and Experimental HematologyT32HL120824 · NHLBI · STANFORD UNIVERSITY · PI MAJETI, RAVINDRA · 2014 to 2023
$2.4M
RPE Energy Metabolism and Cell PhenotypeR01EY025790 · NEI · STANFORD UNIVERSITY · PI VOLLRATH, DOUGLAS E. · 2016 to 2021
$2.4M
Animal Research Equipment, Digital Cages & Metabolic, Avoidance, Fear Conditioning, Place Preference, Self-Administration, Open Field, & Microdialysis Systems for Translational NeuroscienceS10OD030452 · OD · STANFORD UNIVERSITY · PI SHAMLOO, MEHRDAD · 2021 to 2021
$743k
NCI NIH HHS R35 CA197745NEI NIH HHS R01 EY025790NHLBI NIH HHS T32 HL120824NIDDK NIH HHS R01 DK115728NIDDK NIH HHS U01 DK085527NIH HHS S10 OD030452NINDS NIH HHS R01 NS100904
6 · The paper itself

Abstract

Derangements of the blood-brain barrier (BBB) or blood-retinal barrier (BRB) occur in disorders ranging from stroke, cancer, diabetic retinopathy, and Alzheimer's disease. The Norrin/FZD

Indexed as

Blood-Brain BarrierFrizzled ReceptorsAnimalsBlood-Retinal BarrierMiceRetinaWnt Signaling PathwayFrizzled Receptors

Identifiers

PMID37268690
PMCPMC10238527
OpenAlexW4379197309

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.